SCHEMBL27418707

SCHEMBL27418707

CCCCCCn1cc(Nc2ncc(C(=O)OCC)c(Nc3cccc(-c4ncn(C)n4)c3OC)n2)cn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK3 P52333 14/20 0.50
▸ JAK1 P23458 11/20 0.48
▸ JAK2 O60674 10/20 0.48
▸ TYK2 P29597 4/20 0.44
▸ HDAC3 O15379 2/20 0.43
▸ HDAC4 P56524 2/20 0.43
▸ HDAC1 Q13547 2/20 0.43
▸ HDAC7 Q8WUI4 2/20 0.43
▸ HDAC2 Q92769 2/20 0.43
▸ HDAC10 Q969S8 2/20 0.43
▸ HDAC11 Q96DB2 2/20 0.43
▸ HDAC8 Q9BY41 2/20 0.43
▸ HDAC6 Q9UBN7 2/20 0.43
▸ HDAC9 Q9UKV0 2/20 0.43
▸ HDAC5 Q9UQL6 2/20 0.43
▸ USP2 O75604 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27418635 1.00 JAK3 (0.50) JAK3JAK1JAK2TYK2HDAC3
SCHEMBL31711639 0.92 JAK3 (0.52) JAK3JAK1JAK2TYK2HDAC3
SCHEMBL27418733 0.92 JAK3 (0.52) JAK3JAK1JAK2TYK2HDAC3
SCHEMBL27418652 0.92 JAK3 (0.52) JAK3JAK1JAK2TYK2HDAC3
SCHEMBL31711617 0.92 JAK3 (0.52) JAK3JAK1JAK2TYK2HDAC3
SCHEMBL27415143 0.91 JAK3 (0.60) JAK3JAK1JAK2TYK2
SCHEMBL27415211 0.91 JAK3 (0.60) JAK3JAK1JAK2TYK2
SCHEMBL31711634 0.91 JAK3 (0.60) JAK3JAK1JAK2TYK2
SCHEMBL27419078 0.91 JAK3 (0.50) JAK3JAK1JAK2TYK2USP2
SCHEMBL31711643 0.90 JAK3 (0.49) JAK3JAK1JAK2TYK2USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024137548-A2 INHIBITORS OF JAK2 Llydaw Therapeutics, Inc. (US) 2024-06-27 — — WO disclosed
Send feedback